Medis Medical Quantification Software - New QAngio® CT Quantification Software Helps Detect Vessel Abnormalities in CTA Studies

News and Events > Press Releases

New QAngio® CT Quantification Software Helps Detect Vessel Abnormalities in CTA Studies

LEIDEN, the Netherlands -- September 21, 2006 -- Computed Tomography Angiography presents radiologists and cardiologists with data sets that contain valuable information on vessel abnormalities. To post-process the large quantity of data offered by CTA and quickly detect vessel abnormalities, Medis presents its new software solution QAngio CT.

QAngio CT quickly and reliably quantifies cardiac and peripheral CTA studies, which helps radiologists and cardiologists detect the narrowing or obstruction of arteries and assess the severity of these abnormalities. It minimizes time spent on interpreting CTA data and it is independent of CT scanner brand or type.

Key features include:

calculation of stenosis degree, stenosis length and a range of vessel segment data
manual or automatic determination of stenosis and reference segments
MPR, Curved MPR and 3D views
export of analysis results in PDF, DICOM SR and DICOM SC
PACS connectivity

For this CT solution, Medis has built on more than fifteen years of experience gained with automated segmentation in cardiac quantification analysis software. The cardiac X-ray equivalent QAngio® XA (formerly known as QCA-CMS™) is the gold standard quantification solution for coronary angiograms. QAngio CT is expected to be available on the US market and in other countries worldwide in Q4, 2006. The product has been cleared for market by the FDA. It will be introduced at the RSNA 2006.

About Medis

Medis medical imaging systems is a leading provider of innovative quantification software solutions that enable clinicians, technicians and researchers to accurately quantify medical images. The company offers software solutions for the medical specialties of cardiology and radiology, and for the modalities MRI, MSCT, X-ray angiography and intravascular ultrasound. Medis' global headquarters are in Leiden, the Netherlands, and the company has a subsidiary in Leesburg, VA, USA.

For more information, contact:

Hans H.C. Reiber, PhD
President and CEO
+31 (0) 71 522 32 44
www.medis.nl